137 related articles for article (PubMed ID: 9573034)
1. The Ig heavy chain 3' end confers a posttranscriptional processing advantage to Bcl-2-IgH fusion RNA in t(14;18) lymphoma.
Petrovic AS; Young RL; Hilgarth B; Ambros P; Korsmeyer SJ; Jaeger U
Blood; 1998 May; 91(10):3952-61. PubMed ID: 9573034
[TBL] [Abstract][Full Text] [Related]
2. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
[TBL] [Abstract][Full Text] [Related]
4. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.
Matolcsy A; Casali P; Warnke RA; Knowles DM
Blood; 1996 Nov; 88(10):3937-44. PubMed ID: 8916960
[TBL] [Abstract][Full Text] [Related]
5. BCL-2 regulation targeting the AU-rich domain.
Bevilacqua A; Ceriani MC; Schiavone N; Nicolin A
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1273-9. PubMed ID: 11097057
[TBL] [Abstract][Full Text] [Related]
6. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.
Fenton JA; Vaandrager JW; Aarts WM; Bende RJ; Heering K; van Dijk M; Morgan G; van Noesel CJ; Schuuring E; Kluin PM
Blood; 2002 Jan; 99(2):716-8. PubMed ID: 11781262
[TBL] [Abstract][Full Text] [Related]
7. Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter study.
Darby AJ; Lanham S; Soubeyran P; Johnson PW
Haematologica; 2005 Dec; 90(12):1706-7. PubMed ID: 16330451
[TBL] [Abstract][Full Text] [Related]
8. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.
Voso MT; Hohaus S; Moos M; Haas R
Blood; 1997 May; 89(10):3763-8. PubMed ID: 9160682
[TBL] [Abstract][Full Text] [Related]
9. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
10. Alternative end-joining in follicular lymphomas' t(14;18) translocation.
Marculescu R; Le T; Böcskör S; Mitterbauer G; Chott A; Mannhalter C; Jaeger U; Nadel B
Leukemia; 2002 Jan; 16(1):120-6. PubMed ID: 11840271
[TBL] [Abstract][Full Text] [Related]
11. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
[TBL] [Abstract][Full Text] [Related]
12. Novel bcl-2 breakpoints in patients with follicular lymphoma.
Wang YL; Addya K; Edwards RH; Rennert H; Dodson L; Leonard DG; Wilson RB
Diagn Mol Pathol; 1998 Apr; 7(2):85-9. PubMed ID: 9785006
[TBL] [Abstract][Full Text] [Related]
13. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.
Murga Penas EM; Callet-Bauchu E; Ye H; Gazzo S; Berger F; Schilling G; Albert-Konetzny N; Vettorazzi E; Salles G; Wlodarska I; Du MQ; Bokemeyer C; Dierlamm J
Blood; 2010 Mar; 115(11):2214-9. PubMed ID: 19965626
[TBL] [Abstract][Full Text] [Related]
14. Unusual deletions in the immunoglobulin heavy chain locus in follicular B-cell lymphoma with t(14;18)(q32.3;q21.3).
Dyer MJ
Genes Chromosomes Cancer; 1993 Dec; 8(4):270-2. PubMed ID: 7512371
[No Abstract] [Full Text] [Related]
15. [Clinical and molecular pathogenesis of follicular lymphoma].
Karube K
Rinsho Ketsueki; 2008 Mar; 49(3):159-64. PubMed ID: 18421956
[No Abstract] [Full Text] [Related]
16. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.
Duan H; Xiang H; Ma L; Boxer LM
Oncogene; 2008 Dec; 27(53):6720-8. PubMed ID: 18695675
[TBL] [Abstract][Full Text] [Related]
17. [t(14:18) chromosomal translocation and over expression of bcl-2 protein in follicular type non-Hodgkin's lymphoma].
Wang J; Li G; Liu Z
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):337-40. PubMed ID: 8732086
[TBL] [Abstract][Full Text] [Related]
18. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Chesi M; Nardini E; Lim RS; Smith KD; Kuehl WM; Bergsagel PL
Blood; 1998 Nov; 92(9):3025-34. PubMed ID: 9787135
[TBL] [Abstract][Full Text] [Related]
19. t(14;18) chromosomal translocation in follicular lymphoma: an event occurring with almost equal frequency both at the D to J(H) and at later stages in the rearrangement process of the immunoglobulin heavy chain gene locus.
Stamatopoulos K; Kosmas C; Belessi C; Papadaki T; Afendaki S; Anagnostou D; Loukopoulos D
Br J Haematol; 1997 Dec; 99(4):866-72. PubMed ID: 9432035
[TBL] [Abstract][Full Text] [Related]
20. Novel secondary Ig VH gene rearrangement and in-frame Ig heavy chain complementarity-determining region III insertion/deletion variants in de novo follicular lymphoma.
Kobrin C; Bendandi M; Kwak L
J Immunol; 2001 Feb; 166(4):2235-43. PubMed ID: 11160277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
